←Front page
HealthNational

Lupus Foundation of America─supported phase II trial shows promise for mesenchymal stromal cells as a potential new lupus therapy

New data from the Lupus Foundation of America (LFA)–funded phase II Mesenchymal Stromal Cells in Systemic Lupus Erythematosus (MiSLE) trial, evaluating a single infusion of umbilical cord─derived mesenchymal

0

Balanced coverage

0% L100% C0% R

1 outlet covering this story

Bias Comparison

No AI summary generated for this bucket yet.

1 Article

Discussion (0)

Sign in to share your opinion.
  • No comments yet — be the first to weigh in.